Revenue

As its National Wine Day turns 25, see how Moldova turned post-Soviet crisis into an award-winning wine powerhouse and a top tourism destination.

Emmy-winner Brandon McMillan will unveil a revolutionary new line of dog training tools at the pet industry's premier event. What does he have in store?

Blue Cross divests its profitable insurance arm to Enstar Group, a move to bolster its core healthcare mission amid rising costs and industry shifts.

With triple-digit loan volume growth and a landmark AAA rating, Figure Technology Solutions' latest results suggest tokenized assets are finally breaking through.

Elanco's founding chairman and innovation head are leaving, marking a pivotal leadership shift as the animal health giant charts its post-spin-off future.

A world-first quantum teleportation over commercial fiber proves a secure, unhackable internet is closer than ever, thanks to a Canadian tech partnership.

Toronto's Xanadu unveils a breakthrough quantum algorithm for chemistry while preparing for a major public listing via a $500 million SPAC deal.

The biohacking boom gets a new tool as QuasarMD expands from facial devices to full-body recovery, targeting a market projected to exceed $100 billion.

Industry heavyweight Rick Seehausen takes the helm at Lenders One, a strategic move by Altisource to arm independent lenders for a shifting market.

The exclusive access app is expanding beyond dining, using AI and human editors to solve 'cultural overwhelm' for its affluent, globe-trotting members.

The esports betting firm has paused all player activity and announced massive layoffs, signaling a potential sale amid a deepening financial crisis.

A new book reveals why physician marriages are surprisingly stable and what every dual-career couple can learn from their success in balancing love and life.

Tacoma-based Columbia Banking System holds its quarterly dividend at $0.37, reflecting strong earnings and strategic growth in a complex regional market.

A new ETF, EXEQ, uses AI to score and invest in corporate leadership, aiming to turn a qualitative trait into a data-driven source of returns.

With a $15 million funding boost, Nasus Pharma is accelerating its powder-based intranasal epinephrine, NS002, challenging the EpiPen's dominance.

Couples are now using Valentine's Day to plan luxury destination weddings, with immersive pre-wedding trips to places like Switzerland gaining popularity.

Paris reaffirms support for the Africa Adaptation Acceleration Program, a move signaling deeper diplomatic ties and a focus on African-led solutions.

Las Vegas Sands names Patrick Dumont CEO, signaling a new chapter focused on executing massive multi-billion dollar investments in Macao and Singapore.

A U.S. firm enters Puerto Rico's embattled water market, promising advanced filtration for hospitals and hotels plagued by infrastructure woes.

The firm reports a $195M cash reserve but a wider net loss as it nears crucial data readouts for its novel depression and anxiety drug candidates.